Kyowa Kirin Receives Positive CHMP Opinion for Use of CRYSVITA® ?(burosumab) for the Treatment of Tumour-Induced Osteomalacia (TIO)

4 years ago

CRYSVITA could offer access to the first biologic treatment for EU patients with TIO who cannot undergo surgical removal of…

Dr. Reddy’s Laboratories Announces the Acquisition of an Injectable Product Portfolio from Eton Pharma

4 years ago

HYDERABAD, India & PRINCETON, N.J.--(BUSINESS WIRE)--$RDY #Acquisition--Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with…

Locix’s Warehouse Intelligence Solution Deployment Named a Recipient of Supply & Demand Chain Executive’s Top Supply Chain Projects Awards

4 years ago

This award spotlights successful and innovative transformation projects that deliver bottom-line value to small, medium, and large enterprises across a…

Propanc Biopharma Announces No Immediate Plans for Reverse Stock Split

4 years ago

Company Filed a Definitive Information Statement Under Section 14C of the Exchange Act MELBOURNE, Australia--(BUSINESS WIRE)--Propanc Biopharma, Inc. (OTCQB: PPCB)…

Entegris and CMC Materials Receive China Antitrust Clearance for Pending Acquisition

4 years ago

Transaction Expected to Close on July 6, 2022 BILLERICA, Mass. & AURORA, Ill.--(BUSINESS WIRE)--Entegris, Inc. (NASDAQ: ENTG) and CMC Materials,…

Growing Number of CAGR of 4.3% from 2022 to 2030, mTOR Inhibitors Market Size to USD 9,445 Mn by 2030 Report By Acumen Research and Consulting

4 years ago

Acumen Research and Consulting recently published report titled “mTOR Inhibitors Market Size, Share, Analysis Report and Region Forecast, 2022 -…

Biolexis and Akston Biosciences Announce Encouraging Top-Line Results from Phase II/III Trial of their Thermostable 2nd Gen COVID-19 Vaccine

4 years ago

Results of 100 subjects bridging study and 1,500 subjects placebo-controlled trial of Akston’s AKS-452 announced. Interim analysis shows a 91%…

Biolexis and Akston Biosciences Announce Encouraging Top-Line Results from Phase II/III Trial of their Thermostable 2nd Gen COVID-19 Vaccine

4 years ago

Results of 100 subjects bridging study and 1,500 subjects placebo-controlled trial of Akston’s AKS-452 announced. Interim analysis shows a 91%…

Thailand Telecoms, Mobile and Broadband Market Analyses Report 2022 – ResearchAndMarkets.com

4 years ago

DUBLIN--(BUSINESS WIRE)--The "Thailand - Telecoms, Mobile and Broadband - Statistics and Analyses" report has been added to ResearchAndMarkets.com's offering. Thailand…

Thailand Telecoms, Mobile and Broadband Market Analyses Report 2022 – ResearchAndMarkets.com

4 years ago

DUBLIN--(BUSINESS WIRE)--The "Thailand - Telecoms, Mobile and Broadband - Statistics and Analyses" report has been added to ResearchAndMarkets.com's offering. Thailand…